Overview of the Use of Optical Coherence Tomography Angiography in Neovascular Age-Related Macular Degeneration.
Henrik FaatzAlbrecht LommatzschPublished in: Journal of clinical medicine (2024)
The aim of this review is to present and discuss the use of optical coherence tomography angiography (OCTA) in age-related macular degeneration (AMD). OCTA is a non-invasive imaging procedure that gives a detailed indirect view of physiological and pathological vessels in the retina and choroid membrane. Compared with dye-based imaging, OCTA provides a segmented presentation of the individual vascular layers and plexuses, thus enabling previously unattainable differentiation and classification of pathological vascular changes within or underneath the retina. In particular, OCTA facilitates early detection of exudative macular neovascularizations (MNV) so that treatment with anti-VEGF medication can be initiated. Moreover, in the context of both screening and therapy monitoring, it is hoped that OCTA can provide more detailed data to enable greater personalization of treatment and follow-up. The image quality of OCTA is, however, susceptible to artifacts, and validation of the results by studies is required. Recent developments have shown constant improvement both in the algorithms for image calculation and avoidance of artifacts and in image quality, so the scope of OCTA will certainly expand with time.
Keyphrases
- age related macular degeneration
- image quality
- computed tomography
- deep learning
- machine learning
- high resolution
- diabetic retinopathy
- dual energy
- healthcare
- stem cells
- endothelial cells
- electronic health record
- big data
- artificial intelligence
- combination therapy
- optic nerve
- optical coherence tomography
- chemotherapy induced